Literature DB >> 18838078

Alternative splicing: a key mechanism for ankyrin-B functional diversity?

Ralph J van Oort, Julio Altamirano, W J Lederer, Xander H T Wehrens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838078      PMCID: PMC2606664          DOI: 10.1016/j.yjmcc.2008.08.016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  16 in total

Review 1.  Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues.

Authors:  V Bennett; A J Baines
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

2.  Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B.

Authors:  Shane R Cunha; Naina Bhasin; Peter J Mohler
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

3.  Subcellular targeting of phosphatases: a novel function of ankyrins.

Authors:  Ralph J van Oort; Xander H T Wehrens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-20       Impact factor: 4.733

4.  Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.

Authors:  Shane R Cunha; Solena Le Scouarnec; Jean-Jacques Schott; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2008-08-27       Impact factor: 5.000

Review 5.  Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart.

Authors:  Shane R Cunha; Peter J Mohler
Journal:  Cardiovasc Res       Date:  2006-03-28       Impact factor: 10.787

6.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Authors:  Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

7.  Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.

Authors:  Naina Bhasin; Shane R Cunha; Malkanthi Mudannayake; Marisa S Gigena; Terry B Rogers; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-06       Impact factor: 4.733

8.  Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway.

Authors:  John S Lowe; Oleg Palygin; Naina Bhasin; Thomas J Hund; Penelope A Boyden; Erwin Shibata; Mark E Anderson; Peter J Mohler
Journal:  J Cell Biol       Date:  2008-01-07       Impact factor: 10.539

9.  Ankyrin-B syndrome: enhanced cardiac function balanced by risk of cardiac death and premature senescence.

Authors:  Peter J Mohler; Jane A Healy; Hui Xue; Annibale A Puca; Crystal F Kline; R Rand Allingham; Evangelia G Kranias; Howard A Rockman; Vann Bennett
Journal:  PLoS One       Date:  2007-10-17       Impact factor: 3.240

10.  Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.

Authors:  Paola Bagnato; Virigina Barone; Emiliana Giacomello; Daniela Rossi; Vincenzo Sorrentino
Journal:  J Cell Biol       Date:  2003-01-13       Impact factor: 10.539

View more
  3 in total

Review 1.  Ankyrin protein networks in membrane formation and stabilization.

Authors:  Shane R Cunha; Peter J Mohler
Journal:  J Cell Mol Med       Date:  2009-10-16       Impact factor: 5.310

2.  Spatio-temporal expression of ANK2 promotes cytokinesis in oocytes.

Authors:  Anna Tetkova; Denisa Jansova; Andrej Susor
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

3.  Simultaneous genome-wide gene expression and transcript isoform profiling in the human malaria parasite.

Authors:  Lindsey B Turnbull; Geoffrey H Siwo; Katrina A Button-Simons; Asako Tan; Lisa A Checkley; Heather J Painter; Manuel Llinás; Michael T Ferdig
Journal:  PLoS One       Date:  2017-11-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.